Surfactant Protein-D (SP-D), a member of the collectin family, is expressed in the lung and in lower abundance in many other organs (1) . SP-D binds microbial cell-surface carbohydrates by a lectin-mediated mechanism (2) . In some cases such binding has been shown to facilitate phagocytosis; in other cases, agglutination of microorganisms has been observed (3) . SP-D is also chemotactic for neutrophils and mononuclear phagocytes and has been shown to stimulate an oxidant burst from macrophages in vitro (4, 5) . Such observations have led to the general notion that SP-D recognizes non-host carbohydrates, both altering inflammatory cell responses to bound pathogens and facilitating their physical clearance. Thus, SP-D is believed to play an important role in intrinsic immunity in the lung.
SP-D has also been shown to reduce the in vitro proliferation of T lymphocytes in response to Con A, PHA, and anti-CD3 antibodies by a non-lectin-mediated mechanism (6) . Purified SP-D reduces the proliferation of peripheral blood mononuclear cells isolated from patients with asthma when exposed to phytohemagglutinin or dust mite allergen (7) . Reduced proliferation appeared to be mediated by interaction of SP-D with inflammatory cells. SP-D was also shown to reduce mite allergen-induced histamine release from whole blood from mite-sensitive individuals with asthma. The mechanism for inhibition of histamine release appeared to be dependent upon interaction of SP-D with allergen and was mediated by interaction with antigen carbohydrate (7) . Therefore, SP-D may not only have direct effects on lymphocytes, inhibiting their activation and proliferation, but also may prevent inflammatory cell responses to certain antigens. Such observations have led to the hypothesis that SP-D may in part account for the induction and maintenance of a state of reduced immunologic response observed in lung leukocytes (6, 7) . Thus, SP-D may have a role in innate immunity and also in regulating clonal immunity in the lung.
The availability of transgenic mice that do not express SP-D or alternatively express supraphysiologic levels of SP-D has allowed in vivo assessment of the role of SP-D (8) (9) (10) . In the absence of any apparent infectious process, transgenic mice that do not express SP-D accumulate approximately a 6-fold increase in alveolar surfactant (8, 9) . In SP-D null (SP-D Ϫ / Ϫ ) mice, alveolar macrophages are also markedly increased by 10 wk of age (8, 9) . Many alveolar macrophages are enlarged and contain inclusions that stain for either phospholipid or neutral lipid, but most alveolar macrophages have normal morphology (9) . Alveolar macrophages from SP-D Ϫ / Ϫ mice are also activated because they produce increased concentrations of reactive oxygen species and also secrete matrix metalloproteinases (11) . Another pathologic finding is the appearance of peribronchial and perivascular aggregates of lymphocytes without evidence of acute inflammation (8, 9) .
Because SP-D Ϫ / Ϫ mice display increased peribronchial lymphoid aggregates, we sought to determine if there were increased numbers of lymphocytes in the lungs of SP-D Ϫ / Ϫ mice, if their distribution between lymphocyte classes was altered, and if such lymphocytes displayed markers of activation.
Materials and Methods

Transgenic Mice
All mice used for this protocol were housed in the animal care facility at Denver Health Medical Center under standard vivarium conditions. SP-D Ϫ / Ϫ mice were generated using a neomycin replacement strategy with deletion of the second exon of the SP-D gene by homologous recombination. The second exon contains the initiating AUG codon. These mice have previously been described and do not make SP-D protein (9) . All experimental mice resulted from 8 sequential outbreedings of the founding strain (129 Ola/Swiss Black hybrids) into a commercially available NIH Black Swiss outbred strain (Taconic, Germantown, NY). Swiss Black outbred mice were chosen for evaluation because the phenotype was first observed in the founding hybrids and persisted through successive outbreedings. However, similar collections of lymphocytes have been observed in SP-D Ϫ / Ϫ mice derived from different parental strains (8) mice were littermates from heterozygous crosses and all were apparently healthy and of equal weight. Every mouse used in these experiments was genotyped by PCR and DNA blot analysis as previously described (9) . Mice were killed by lethal pentobarbital injection followed by exsanguination at 6-12 wk of age. Lungs and spleens were removed and placed in iced phosphate-buffered saline (PBS) until analysis was performed (within 2 h).
Flow Cytometric Analysis of Lung and Spleen Cells
Lymphocyte analysis was performed as previously described (12) . Lung lobes were minced with scissors in a 35-mm tissue culture dish and then digested in a solution of 1.9 mg/ml collagenase, DNase at 10 U/ml, and soybean-trypsin inhibitor at 10 g/ml in tissue culture medium with 5% fetal bovine serum (all reagents were from Sigma Chemical Co., St Louis, MO) in the same dish. Lung tissues were incubated in the digestion solution for 1 h at 37 Њ C, then triturated through a #20 needle. The entire cell suspension was then passed through a 70-M centrifugal filter (BD Falcon, Bedford, MA). Mononuclear cells were isolated from the filtrate by Ficoll density gradient centrifugation and the total number of viable mononuclear cells recovered from each lung was determined by manual counting. Spleen cells were obtained after mechanical disruption and erythrocytes were lysed by ammonium chloride. A second set of experiments was performed to eliminate the potential for erroneous assessment of lymphocyte lineages from lymphocytes in the pulmonary circulation. After bronchoalveolar lavage (BAL), the lungs were perfused free of blood using 10 ml of PBS, 5 mM EDTA. Lymphocytes from disassociated lung tissue were analyzed by fluorescence-activated cell sorter (FACS). Cells were analyzed using a FACSCalibur flow cytometer (Becton Dickinson, Palo Alto, CA), with analysis gates set by gating on unstained spleen lymphocytes. Between 10,000 and 30,000 gated events were analyzed for each cell population. Isotype controls have been performed on previous occasions for each antibody used, and background has not been significant; therefore isotype controls were not duplicated for these experiments (12) . Data was analyzed using Repromac software (True Facts Software, Seattle, WA) and the percentage of each cell type in the total lung and spleen mononuclear population was determined.
For analysis of T cell activation, cells were immunostained with anti-␣␤ TCR antibody (biotin H57.597; Pharmingen, San Diego, CA) and with antibodies to either CD4 (FITC RM4-5; Pharmingen) or CD8 (FITC 53-6.7; Pharmingen), and with anti-CD69 (Very Early Activation Antigen) (PE, H1.2F3; Pharmingen). NK cells were labeled using a pan NK cell marker (biotin The T cell memory population was assessed by quantifying the level of expression of CD62 ligand (L-selectin) on CD4 ϩ T cells that also express high levels of CD44. T cells that express low levels of CD62L and high levels of CD44 are considered to represent the memory cell population (13) . Cells were labeled with antibodies to CD4 or CD8, CD44 (PE: 1M7; Pharmingen), and CD62L (biotin MEL-14; Pharmingen).
To determine if BAL lymphocytes were activated, SP-D
and SP-D Ϫ / Ϫ mice 6 wk of age were killed and underwent BAL using PBS, 5 mM EDTA (pH 7.4) as previously described (9) . BAL cells were pelleted at 1,000 ϫ g for 10 min, resuspended in PBS, and subjected to FACS analysis.
Analysis of T Cell Receptor V ␤ Repertoire of Intrapulmonary T Cells
Intrapulmonary mononuclear cells were stained with antibodies to CD4 or CD8 and biotinylated antibodies to the following T cell receptor V ␤ chains: Vb2, 3, 8, 11, and 14; all antibodies from Pharmingen). Cells were washed and stained with streptavidin-PE and then analyzed by flow cytometry.
Enzyme-Linked Immunosorbent Assays for Spontaneous Cytokine Release
The enzyme-linked immunosorbent assays (ELISA) for murine IL-2, IL-4, and IL-10 were purchased from Pharmingen and were performed according to the manufacturer's directions. The ELISAs for total IL-12 and tumor necrosis factor (TNF)-␣ were purchased for Genzyme (Boston MA). The ELISA for murine interferon (IFN)-␥ was performed using the XMG1.2 mAB as a capture antibody and biotinylated R4GA2 mAb as the detecting antibody. Concentrations of the IFN-␥ were determined by comparison to a standard curve generated with recombinant murine IFN-␥ (R&D Systems, Minneapolis, MN). Cytokine concentrations were determined in tissue culture supernatants obtained from unstimulated cell cultures after 18 h in vitro incubation. Cells from lungs and spleen tissues were cultured in complete medium at a final concentration of 2.5 ϫ 10 5 /ml (lungs) and 1 ϫ 10 6 /ml (spleens). The supernatants were harvested and stored at 4 Њ C before analysis. Each sample was assayed in duplicate, with four mice per assay.
Immunostaining
Formalin-fixed paraffin embedded sections were deparaffinized and rehydrated. Endogenous peroxidase was blocked by incubation in 3% H 2 O 2 in methanol for 10 min. Antigen retrieval was done using Retrievagen A solution from BD Biosciences (San Diego, CA). Slides were blocked with 3% goat serum and 0.2% Tween in PBS for 30 min and washed with three changes of PBS. Primary antibody, rat anti-CD45 BD (BD Biosciences), was diluted 1:50 in PBS 0.2% Tween 3% goat serum and incubated overnight at 4 Њ C and washed with three changes of PBS. Secondary antibody, biotinylated mouse anti-rat IgG (BD Biosciences), was applied in PBS 3% goat serum for 30 min followed by washing three times with PBS. A Vectastain ABC kit from Vector Labs (Burlingame, CA) was used according to the manufacturers directions using Vector Red staining and haematoxylin counterstain.
Morphometric Analysis
Both lungs from each of six SP-D Ϫ / Ϫ and six SP-D ϩ / ϩ mice were stained with CD45 and used to estimate lymphocyte abundance in three compartments. Interstitial lymphocytes were defined as lymphocytes present in the interstitium of alveoli. Intra-alveolar cells were not scored. Airway-associated lymphocytes were defined as lymphocytes contiguous with the airway epithelium, airway adventitial tissues, or mononuclear cells which were contiguous with the airway tissues. Vessel-associated lymphocytes were defined as lymphocytes contiguous with vessels, vascular adventitial tissues, or vessel-associated mononuclear cells. Twenty randomly chosen fields of 16 M 2 were scored for each section with one section for each lung. Because the data was not normally distributed, the Kruskal-Wallis test was used to evaluate differences in lymphocyte density in each of the three compartments be-
Assessment of Lymphocyte Proliferation
Age-matched mice were given 600 l BrdU solution (Amersham, Piscataway, NJ) intraperitoneally and killed 24 h later. BAL was performed and the lungs were perfused free of blood, after which they were minced, subjected to enzymatic digestion, and collected on a density step gradient (12) . Cytospins were performed from BAL and lung mononuclear cells using at least 50,000 cells. Cytospin slides were stained for PCNA and BrdU using kits obtained from Zymed Laboratories (South San Francisco, CA) following the directions of the manufacturer. Proliferation of lymphocytes was determined by assessing the number of lymphocytes that stained positive for either marker. Six mice of each genotype were analyzed, and 100 lymphocytes per mouse counted. Significance was assessed using an unpaired t test.
RNase Protection Assays
Assays were performed using RiboQuant Multi-Probe RNase Protection Assay kits supplied by Pharmingen. Total lung RNA was purified using the acid phenol extraction method. Templates were labeled following recommendations of the kit manufacturer. Ten micrograms of total lung RNA was hybridized with labeled templates for 16 h, treated with RNase, extracted with phenol/chloroform:isoamyl alcohol and precipitated with ethanol. Protected fragments were resolved on Life Technologies S2 vertical slab gel electrophoresis apparatus (Gibco, Gaithersburg, MD) using a 5% polyacrylamide gel. Autoradiography was performed for various times to evaluate both abundant and rare transcripts.
Semiquantitative analysis was performed with scanning densitometry using a Bio-Rad scanning densitometer (Hercules, CA). All fragment intensities were normalized for glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA abundance. For comparisons, four or five mice of each genotype were evaluated twice and normalized band intensity averaged for each mouse. Normal mouse signal was arbitrarily assigned a value of 100. SP-D
ϪրϪ mice values were expressed as a fraction of the normal mouse value. Not all cytokines assayed by the kits were sufficiently abundant to be detected by the assay and were not reported. Differences in cytokine mRNA abundance were analyzed with GraphPad In-Stat statistics package (San Diego, CA) using oneway ANOVA. Because there were more than five groups, the Tukey post hoc test was applied. Statistical significance was a P value of Ͻ 0.05.
IL-5 RT-PCR
To estimate IL-5 transcript abundance, RT-PCR was performed as follows: after DNase treatment, 200 ng each total RNA from four SP-D Ϫ / Ϫ and four SP-D ϩ / ϩ mice was subjected to reverse transcription, using 25 U MuLV reverse transcriptase (Applied Biosystems, Foster City, CA). Following RT, 10% of the RT mix was subjected to 40-cycle PCR using a murine IL-5 Amplifluor Cytokine Direct Gene Systems fluorescence assay kit (Intergen, Purchase, NY) according to the recommendations of the supplier. These methods were sufficient to reliably detect a 25% difference in input RNA. Similar efficiencies of RT and PCR were demonstrated using primers for ␤ -actin and results were normalized for ␤ -actin abundance after RT-PCR.
Results
Ten-week-old female SP-D
Ϫ / Ϫ and SP-D ϩ / ϩ littermates from a heterozygous cross were caged together from birth. Both DNA blot analysis and PCR of tail-clip DNA were used to confirm genotypes. Representative sections are shown in Figure 1 . In SP-D Ϫ / Ϫ mice, lymphocytes are visible near airways, small and large pulmonary vessels adjacent to airways, and also pulmonary veins adjacent to lobar septae. Similar collections of lymphocytes were not seen in SP-D ϩ / ϩ littermates using H&E staining.
CD45 staining was conducted to identify collections of marrow-derived cells. In Figure 2 phocytes. Lymphoid aggregates are not prominent in the interstitium, in airway lumens, or in the alveolar airspace. Collections of lymphocytes are often seen in close proximity to enlarged alveolar macrophages. Similar lymphocytic aggregates have been seen in 4/4 SP-D Ϫ/Ϫ mice. Collections of lymphocytes were apparent in (4/4) matched SP-D ϩ/ϩ littermates in similar locations, but they were markedly smaller and also less abundant. In total, mice from four separate litters were evaluated morphologically.
To determine the total number of lung mononuclear cells and their distribution between subtypes in SP-D Ϫ/Ϫ and SP-D ϩ/ϩ littermates, whole lung and spleen were minced, enzymatically disassociated, and filtered through a 70-M centrifugal filter. Viable cells were counted before and after sedimentation through a Ficoll gradient and efficiency of mononuclear cell isolation was identical between SP-D Ϫ/Ϫ and SP-D ϩ/ϩ mice. Total numbers of lung mononuclear cells exclusive of pulmonary macrophages were not significantly different between null and normal mice, as shown in Figure 3A . Because the numbers of lymphocytes appeared to be increased by both H&E staining and CD45 immunohistochemical staining, we evaluated our lung disassociation protocol. Cytospin analysis of disassociated lung before filtration demonstrated aggregates of undigested airway epithelium, which in the case of SP-D Ϫ/Ϫ mice was associated with lymphocytes by CD45 staining. Aggregates could be eluted from the 70-M filter retentate and were therefore not subjected to density gradient (data not shown). Such aggregates of airway cells and lymphocytes therefore may not be well represented in lymphocytes obtained from disassociated lung. Total lung lymphocytes could therefore be underestimated. The distribution of lymphocytes between CD4 ϩ , CD8 ϩ , NK, and B cell lineages is shown in Figure 3B and was likewise not significantly different between genotypes (P Ͼ 0.05).
Because lymphoid aggregates were apparent in SP-D Ϫ/Ϫ mice, but increased numbers of lymphocytes were not observed by FACS analysis of disassociated lung, we performed morphometric analysis of CD45-stained lung sections ( Figure 4 ). We found significantly increased numbers of airway-and vessel-associated lymphocytes in SP-D
mice but did not demonstrate significant differences in interstitial lymphocytes. Therefore redistribution of lymphocytes from interstitial to airway and vascular regions is unlikely. We believe that our data may be explained by inadequate digestion of peribronchial tissues and must be interpreted cautiously because lymphocytes from those regions may have been poorly represented in samples subjected to FACS analysis. To assess pulmonary lymphocyte activation, expression of CD69 (early activation antigen) and CD25 (IL-2 recep- tor) was determined flow cytometrically. In Figure 5A ϩ and CD ϩ T cells in SP-D Ϫ/Ϫ mice (data not shown), whereas there was no difference in CD25 expression by spleen lymphocytes in either group of mice. Mouse lungs subjected to both BAL and vascular perfusion showed results that were not significantly different from mice analyzed without vascular perfusion and BAL.
When BAL lymphocytes were subjected to FACS analysis, there was approximately a 4-to 5-fold increase in the abundance of CD4 ϩ and CD8 ϩ lymphocytes in BAL from SP-D Ϫ/Ϫ mice (n ϭ 6 per genotype, P Ͻ 0.02 by the MannWhitney test). There was a 6-fold increase in the number of SP-D Ϫ/Ϫ CD4 lymphocytes expressing CD69 (P Ͻ 0.02 by the Mann-Whitney test). There was a 4-fold increase in the abundance of CD8 lymphocytes from SP-D Ϫ/Ϫ that expressed CD69, but the difference was not statistically significant (P Ͼ 0.05). Confirming previous observations at the light microscopy level, there was a 6-fold increase in cells expressing Mac1 in BAL from SP-D Ϫ/Ϫ mice (P Ͻ 0.01) even when large alveolar macrophages were excluded by forward scatter.
Memory T lymphocytes express high levels of CD44 and low levels of CD62 ligand (L-selectin), indicating previous antigen exposure, whereas naive lymphocytes ex- We also evaluated pulmonary T cells for evidence of either oligoclonal expansions or deletions. This was done to determine if in the absence of SP-D, there might have been preferential activation and expansion of one or several clones of T cells responding to one or a few dominant antigens. Such a response might be reflected as an increase in the population of T cells expressing a certain T cell receptor V␤ chain. Pulmonary T cells (both CD4 ϩ and CD8 ϩ ) were evaluated using antibodies specific for six different T cell receptor V␤ chains. This analysis did not reveal any significant differences in the percentages of pulmonary lymphocytes expressing V␤2, V␤3, V␤6, V␤8, V␤11, or V␤14 in SP-D Ϫ/Ϫ mice compared with SP-D ϩ/ϩ mice (data not shown).
To determine if lymphocytes were polarized to the Th1 or alternatively to the Th2 phenotype, RNase protection assays (RPA) were conducted using RNA from lung homogenate from SP-D Ϫ/Ϫ and SP-D ϩ/ϩ mice. There were statistically significant reductions in Eotaxin and Rantes mRNA ( Figure 7 ). IFN-␥ and IL-4 mRNA was not different but IL-6 expression was increased ‫ف‬ 3-fold in SP-D Ϫ/Ϫ mice. (Table 1) . IL-5 transcript was not sufficiently abundant to identify expression using our RPA methodology. Therefore, to assess differences in IL-5 expression between SP-D Ϫ/Ϫ and SP-D ϩ/ϩ mice, we performed RT-PCR analysis of samples from four age-matched mice of each genotype. There was no significant difference in the abundance of IL-5 transcript by these methods (data not shown). To assess cytokine production, ELISA of supernatants from cultured-disassociated lung mononuclear cells were assayed for IL-2, IL-4, IL-10, IL-12, TNF-␣, and IFN-␥ using commercially available kits. There was 2-fold increase in IL-12 expression by lung mononuclear cells from SP-D Ϫ/Ϫ mice (P Ͻ 0.05) but there was no difference in the expression of other cytokines between SP-D Ϫ/Ϫ and SP-D ϩ/ϩ mice by either lung cells or spleen cells. IL-2 production by lung mononuclear cells from SP-D Ϫ/Ϫ mice was increased 6-to 8-fold but did not reach statistical significance given the small number of samples and high variability (P Ͼ 0.07).
To assess proliferation of BAL and lung tissue lymphocytes, mice were given BrdU 24 h before BAL and lung digestion. Both PCNA and BrdU immunostaining was done on separate slides. Proliferating lymphocytes were identified by positive staining for either antigen. There was a significant difference in proliferation by PCNA staining with 6.7 Ϯ 1.38% SP-D Ϫ/Ϫ lung digest lymphocytes positive for PCNA and 4.8 Ϯ 1.07% SP-D ϩ/ϩ lymphocytes positive for PCNA (P Ͻ 0.02, n ϭ 7/genotype). There was not a significant difference in BAL lymphocyte proliferation between genotypes by PCNA analysis. Incorporation of BrdU into lung and BAL lymphocytes was very low in both genotypes and was also low in bronchial epithelium but incorporation was evident in gastric mucosa. We believe these results can be explained by poor lung penetration of intraperitoneally injected BrdU.
Finally, to determine if activated alveolar macrophages might in turn lead to activation of lung T lymphocytes, equal numbers of BAL alveolar macrophages from SP-D ϩ/ϩ or SP-D Ϫ/Ϫ mice were added to cultured lymphocytes from normal mouse lung and normal mouse spleen for 24 h. Lymphocytes were then subjected to FACS analysis to determine if there were differences in the expression of either CD69 or CD25. There was no difference in expression of activation markers or thymidine incorporation (data not shown).
Discussion
SP-D
Ϫ/Ϫ mice from different genetic backgrounds (8, 9) consistently demonstrate abnormal accumulations of lymphocytes around bronchi and pulmonary vessels. Acute inflammation and local tissue destruction are not apparent. Tissue anti-CD45 immunostaining also demonstrates collections of cells that appear to be lymphocytes in perivascular and peribronchial regions. Such collections are not uniform and are often observed in association with enlarged macrophages, suggesting that SP-D Ϫ/Ϫ macrophages might be responsible for accumulation of lymphocytes. Similar collections of lymphocytes have been described in several models of lung inflammation that are mediated by specific immunoreactivity to inhaled antigens (14) (15) (16) . Our colony of SP-D Ϫ/Ϫ mice is maintained under standard vivarium conditions. We have never been able to document infectious disease in these mice using serologic techniques, bacteriologic and fungal culture, or ribosomal RT-PCR for Chlamydia and Mycoplasma. Therefore it is not likely that such accumulations are due to occult infectious disease.
Contrary to our expectations from examination of lung histology, we did not observe increases in the number of total lung digest lymphocytes in SP-D Ϫ/Ϫ mice. One likely explanation for this observation is that lung tissue was not adequately digested to release peribronchial and perivascular collections of lymphocytes. The presence of aggregates of airway and vascular tissue with lymphocytes after enzymatic digestion supports this conclusion. Morphometric assessment of lymphocyte density by location confirms that there are increases in lymphocytes around airways and vessels without changes in the abundance in interstitial lymphocytes, suggesting that there is an increase in total lung lymphocytes rather than redistribution from the interstitial note compartment. Because there appears to be an increase in total lung lymphocytes by visual inspection and morphometric analysis, it is likely that our methods are not sufficient to estimate total lung lymphocyte abundance. We also may have underestimated the abundance of specific lymphocyte lineages and their activation in the peribronchial/perivascular compartments. This may be very important because antigen may be encountered in those compartments and antigen presentation may be particularly effective in those regions because of the presence of dendritic cells. Our findings must be interpreted with these limitations in mind.
The relative distribution among lymphocyte classes (CD4 There were not, however, significant differences in fractions of B-lymphocytes or NK cells expressing CD69 or CD25 between SP-D Ϫ/Ϫ and normal mice. These findings are consistent with specific activation of CD4 and CD8 lymphocytes by antigen. We demonstrated increased abundance of both CD4 and CD8 lymphocytes in BAL from SP-D Ϫ/Ϫ mice compared with normal littermates. BAL CD4 lymphocytes also demonstrated a statistically significant 6-fold increase in expression of CD69, indicating recent and ongoing activation. CD8 lymphocytes had a 4-fold increase in expression of CD69, though this increase was not statistically significant. Thus, increased numbers of activated T lymphocytes enter the airspace in SP-D Ϫ/Ϫ mice. The entry of activated lymphocytes into the airways of SP-D Ϫ/Ϫ mice may be the result of nonspecific emigration from a pool of activated lymphocytes in lung interstitial tissues or may instead reflect an alteration in the trafficking of lymphocytes as a consequence of the lack of SP-D.
Lymphocytes obtained by lung disassociation from SP-D Ϫ/Ϫ mice demonstrated a significant increase in PCNA staining compared with those from SP-D ϩ/ϩ mice, consistent with increased in situ proliferation. These findings would be expected if lymphocytes in lung tissue were continuously being exposed to antigen in the presence of effective antigen presenting cells. BAL lymphocytes on the other hand, which may be more mature effector cells, did not demonstrate differences between genotypes in PCNA staining. Taken together, these data suggest that the absence of SP-D in the lungs of mice leads to a state of persistent local activation of pulmonary T cells with in situ proliferation and/or increased longevity for lung-associated memory lymphocytes.
To assess the possibility that one or several dominant antigens might be responsible for activation, we analyzed TCR V␤ chain repertoires expressed by intrapulmonary and BAL T lymphocytes. This analysis did not reveal any differences in the T cell receptor repertoire between SP-D Ϫ/Ϫ and normal mice. These methods do not exclude stimulation by a small number of antigens, but reduce the likelihood of that mechanism.
Persistent local T cell activation can be driven by antigens or by overproduction of cytokines such as TNF-␣ or type I interferons (12, 17, 18) . Analysis of cytokine expression by ELISA and RT-PCR showed slight reductions in Eotaxin and Rantes, no difference in IFN-␥ expression, and increases in IL-6 and IL-12 expression in SP-D Ϫ/Ϫ mice compared with SP-D ϩ/ϩ mice. Expression of IL-4, IL-5, and TNF-␣ was not increased; IFN-␣ and IFN-␤ were not measured. Therefore, there was not an overall increase in T cell-activating cytokines, nor was there a clear polarization toward either a Th1-or Th2-promoting environment or phenotype. Additionally, cytokine expression did not seem sufficient to activate T lymphocytes directly. One explanation for such observations is that activated memory T cells may accumulate around airways and vessels in response to an ongoing antigenic stimulus, but the cytokine environment is not sufficient to induce a marked polarization toward either the Th1 or Th2 phenotype.
Exposure to antigen in the presence of LPS leads to prolonged residence of tissue memory lymphocytes, especially in the lung (22) Ribonuclease protection assays were conducted twice using four or five mice of each genotype. Comparisons were made using a densitometric analysis of protected bands each normalized as a fraction of the density of GAPDH. For comparison average, relative density of SP-D ϩ/ϩ mice was arbitrarily assigned a value of 100. Values are represented as a fraction of control Ϯ SD. * P Ͻ 0.05 by t test with Tukey post hoc analysis for multiple comparisons. SP-D Ϫ/Ϫ mice may activate and increase antigen presentation by adjacent antigen-presenting cells such as pulmonary dendritic cells or blood borne monocytes. Additionally, SP-D might alter antigen recognition in regional nodes or the absence of SP-D might increase the number of local dendritic cells that might further facilitate antigen recognition and response. These experiments do not allow conclusions regarding the mechanism by which SP-D regulates lymphocyte proliferation in vivo. For example, it is possible that absence of SP-D may lead to an IL-2-mediated increase in lymphocyte proliferation as has been observed in vitro (6, 7) . Taken together with the relatively modest increases in proinflammatory cytokines in the Lungs of SP-D Ϫ/Ϫ mice, direct lymphocyte activation by cytokines produced by the morphologically abnormal alveolar macrophages that are characteristic of SP-D Ϫ/Ϫ mice seems unlikely. Pulmonary leukocytes are less responsive to antigenic stimuli than peripheral blood leukocytes (19) . In vivo experiments have linked airway lining material to antigenic hyporesonsiveness (20, 21) . Borron and others proposed the hypothesis that SP-D might contribute to inhibition of T cell proliferation in the lung and that this effect might in part account for a relatively antigenic hyporesponsive state in the lung (6) . In vivo deficiency of SP-D leads to activation of pulmonary T-lymphocytes in the absence of activation of B-lymphocytes or NK cells. We did demonstrate findings compatible with activation of T-lymphocytes by an antigen or antigens. Whether antigen recognition or another mechanism is responsible for T cell activation in the lungs of SPD Ϫ/Ϫ mice remains to be clarified.
